EE200000052A - 1,2,4-triasolo[4,3-b]pürido[3,2-d]püridasiini derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon ning nende kasutamine - Google Patents

1,2,4-triasolo[4,3-b]pürido[3,2-d]püridasiini derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon ning nende kasutamine

Info

Publication number: EE200000052A
Authority: EE; Estonia
Prior art keywords: triazolo; pyrido; preparation; pharmaceutical composition; pyridazine derivatives
Prior art date: 1997-07-29

Application number

EEP200000052A

Other languages

English (en)

Inventor

Gracia Ferrer Jordi

Isabel Crespo Crespo Ma

Vega Noverola Armando

Fernandez Garcia Andr�s

Original Assignee

Almirall Prodesfarma S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-29

Filing date

1998-07-13

Publication date

2000-10-16

1998-07-13 Application filed by Almirall Prodesfarma S.A. filed Critical Almirall Prodesfarma S.A.

2000-10-16 Publication of EE200000052A publication Critical patent/EE200000052A/et

2004-06-15 Publication of EE04313B1 publication Critical patent/EE04313B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200000052A 1997-07-29 1998-07-13 1,2,4-triasolo[4,3-b]pürido[3,2-d]püridasiini derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon ning nende kasutamine EE04313B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES009701670A ES2137113B1 (es)	1997-07-29	1997-07-29	Nuevos derivados de triazolo-piridazinas heterociclicos.
PCT/EP1998/004340 WO1999006404A1 (en)	1997-07-29	1998-07-13	1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number	Publication Date
EE200000052A true EE200000052A (et)	2000-10-16
EE04313B1 EE04313B1 (et)	2004-06-15

Family

ID=8300216

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000052A EE04313B1 (et)	1997-07-29	1998-07-13	1,2,4-triasolo[4,3-b]pürido[3,2-d]püridasiini derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon ning nende kasutamine

Country Status (35)

Country	Link
US (2)	US6407108B1 (et)
EP (1)	EP1001955B1 (et)
JP (1)	JP4320118B2 (et)
KR (1)	KR20010022353A (et)
CN (1)	CN1135231C (et)
AR (1)	AR015927A1 (et)
AT (1)	ATE207069T1 (et)
AU (1)	AU737709B2 (et)
BG (1)	BG64448B1 (et)
BR (1)	BR9810829B1 (et)
CA (1)	CA2298935A1 (et)
CO (1)	CO4970780A1 (et)
CZ (1)	CZ290208B6 (et)
DE (1)	DE69802100T2 (et)
DK (1)	DK1001955T3 (et)
EE (1)	EE04313B1 (et)
EG (1)	EG24041A (et)
ES (2)	ES2137113B1 (et)
HU (1)	HUP0004708A3 (et)
ID (1)	ID24506A (et)
IL (1)	IL134081A (et)
MY (1)	MY118796A (et)
NO (1)	NO315118B1 (et)
NZ (1)	NZ502356A (et)
PE (1)	PE111099A1 (et)
PL (1)	PL191031B1 (et)
PT (1)	PT1001955E (et)
RU (1)	RU2202552C2 (et)
SI (1)	SI1001955T1 (et)
SK (1)	SK284046B6 (et)
TR (1)	TR200000243T2 (et)
TW (1)	TW542837B (et)
UA (1)	UA60339C2 (et)
WO (1)	WO1999006404A1 (et)
ZA (1)	ZA986248B (et)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2792938B1 (fr) *	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
SK287231B6 (sk)	1999-08-21	2010-04-07	Nycomed Gmbh	Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
WO2002080974A1 (en) *	2001-04-04	2002-10-17	Sankyo Company, Limited	Novel medicinal use of cytokine production inhibitor
IL160271A0 (en) *	2001-09-19	2004-07-25	Altana Pharma Ag	Pharmaceutical compositions containing pde4-inhibitors and nsaid
FR2832711B1 (fr) *	2001-11-26	2004-01-30	Warner Lambert Co	Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
JP4700965B2 (ja) *	2002-11-06	2011-06-15	あすか製薬株式会社	ピラゾロナフチリジン誘導体
ES2211344B1 (es)	2002-12-26	2005-10-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridazin-3(2h)-ona.
WO2004087211A2 (en)	2003-04-01	2004-10-14	Applied Research Systems Ars Holding N.V.	Inhibitors of phosphodiesterases in infertility
US20050187278A1 (en) *	2003-08-28	2005-08-25	Pharmacia Corporation	Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
RU2246496C1 (ru) *	2003-09-12	2005-02-20	Тец Виктор Вениаминович	Вещество с противовирусной и антибактериальной активностью на основе производных 2,8-дитиоксо-1h-пирано[2,3-d, 6,5-d`] дипиримидина и их 10-аза-аналогов
ES2251866B1 (es)	2004-06-18	2007-06-16	Laboratorios Almirall S.A.	Nuevos derivados de piridazin-3(2h)-ona.
EP1898903B8 (en) *	2005-06-10	2013-05-15	Merck Sharp & Dohme Corp.	Inhibitors of akt activity
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
CA2620333A1 (en)	2005-08-26	2007-03-01	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation
CN101268073B (zh) *	2005-09-15	2011-10-19	Aska制药株式会社	杂环化合物、制备方法及其用途
AU2006304787A1 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en)	2005-10-31	2011-04-27	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
JP2009536667A (ja)	2006-05-09	2009-10-15	ブレインセルス，インコーポレイティド	５ｈｔ受容体介在性の神経新生
EP2021000A2 (en)	2006-05-09	2009-02-11	Braincells, Inc.	Neurogenesis by modulating angiotensin
EP2057164A1 (en)	2006-08-07	2009-05-13	Incyte Corporation	Triazolotriazines as kinase inhibitors
MX2009002496A (es)	2006-09-08	2009-07-10	Braincells Inc	Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
EP3443958A1 (en)	2006-11-22	2019-02-20	Incyte Holdings Corporation	Imidazotriazines and imidazopyrimidines as kinase inhibitors
EP2231669A1 (en) *	2008-01-09	2010-09-29	The U.S.A. As Represented By The Secretary, Department Of Health And Human Services	Phosphodiesterase inhibitors
NZ589622A (en)	2008-05-21	2012-10-26	Incyte Corp	Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EP2196465A1 (en)	2008-12-15	2010-06-16	Almirall, S.A.	(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
US20100216805A1 (en)	2009-02-25	2010-08-26	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
EP2226323A1 (en)	2009-02-27	2010-09-08	Almirall, S.A.	New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
PH12012501361A1 (en)	2009-12-31	2012-10-22	Centro Nac De Investigaciones Oncologicas Cnio	Tricyclic compounds for use as kinase inhibitors
ES2608329T3 (es)	2010-02-03	2017-04-07	Incyte Holdings Corporation	Imidazo[1,2-b][1,2,4]triazinas como inhibidores de c-Met
EP2380890A1 (en)	2010-04-23	2011-10-26	Almirall, S.A.	New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2394998A1 (en)	2010-05-31	2011-12-14	Almirall, S.A.	3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
WO2012098387A1 (en)	2011-01-18	2012-07-26	Centro Nacional De Investigaciones Oncológicas (Cnio)	6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
WO2013005041A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	Tricyclic heterocyclic compounds as kinase inhibitors
WO2013004984A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncologicas (Cnio)	Tricyclic compounds for use as kinase inhibitors
WO2013005057A1 (en)	2011-07-07	2013-01-10	Centro Nacional De Investigaciones Oncológicas (Cnio)	New compounds
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3122670A1 (de)	1981-06-06	1982-12-23	Dr. Karl Thomae Gmbh, 7950 Biberach	"neue 1,4,9,10-tetrahydro-pyrazolo(4,3-e) pyrido(3,2-b)(1,4)diazepin-10-one, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen"
FI81350C (fi) *	1982-01-18	1990-10-10	Lepetit Spa	Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat.
EP0217748B1 (en) *	1985-09-30	1991-02-06	Ciba-Geigy Ag	2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof
AU7238191A (en) *	1990-02-19	1991-09-03	Chugai Seiyaku Kabushiki Kaisha	Novel fused heterocyclic compound and antiasthmatic agent prepared therefrom
PT100938B (pt) *	1991-10-09	1999-10-29	Syntex Inc	Compostos benzo e pirido piridazinona e piridazintiona, composicoes farmaceuticas que os contem, utilizacao dos referidos compostos e processo para a sua preparacao.
GB9514465D0 (en)	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
DE19510965A1 (de) *	1995-03-24	1996-09-26	Asta Medica Ag	Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

1997
- 1997-07-29 ES ES009701670A patent/ES2137113B1/es not_active Expired - Lifetime
1998
- 1998-07-13 WO PCT/EP1998/004340 patent/WO1999006404A1/en not_active Ceased
- 1998-07-13 KR KR1020007000932A patent/KR20010022353A/ko not_active Ceased
- 1998-07-13 PL PL338214A patent/PL191031B1/pl not_active IP Right Cessation
- 1998-07-13 CZ CZ2000333A patent/CZ290208B6/cs not_active IP Right Cessation
- 1998-07-13 ES ES98940218T patent/ES2162466T3/es not_active Expired - Lifetime
- 1998-07-13 SI SI9830042T patent/SI1001955T1/xx unknown
- 1998-07-13 CA CA002298935A patent/CA2298935A1/en not_active Abandoned
- 1998-07-13 EE EEP200000052A patent/EE04313B1/et not_active IP Right Cessation
- 1998-07-13 JP JP2000505162A patent/JP4320118B2/ja not_active Expired - Fee Related
- 1998-07-13 AT AT98940218T patent/ATE207069T1/de not_active IP Right Cessation
- 1998-07-13 DE DE69802100T patent/DE69802100T2/de not_active Expired - Fee Related
- 1998-07-13 PT PT78400158T patent/PT1001955E/pt unknown
- 1998-07-13 SK SK86-2000A patent/SK284046B6/sk not_active IP Right Cessation
- 1998-07-13 IL IL13408198A patent/IL134081A/en active IP Right Grant
- 1998-07-13 AU AU88612/98A patent/AU737709B2/en not_active Ceased
- 1998-07-13 EP EP98940218A patent/EP1001955B1/en not_active Expired - Lifetime
- 1998-07-13 BR BRPI9810829-8A patent/BR9810829B1/pt not_active IP Right Cessation
- 1998-07-13 HU HU0004708A patent/HUP0004708A3/hu unknown
- 1998-07-13 NZ NZ502356A patent/NZ502356A/xx unknown
- 1998-07-13 TR TR2000/00243T patent/TR200000243T2/xx unknown
- 1998-07-13 UA UA2000010486A patent/UA60339C2/uk unknown
- 1998-07-13 DK DK98940218T patent/DK1001955T3/da active
- 1998-07-13 CN CNB988081210A patent/CN1135231C/zh not_active Expired - Fee Related
- 1998-07-13 ID IDW20000180A patent/ID24506A/id unknown
- 1998-07-13 RU RU2000104863/04A patent/RU2202552C2/ru not_active IP Right Cessation
- 1998-07-14 ZA ZA986248A patent/ZA986248B/xx unknown
- 1998-07-16 TW TW087111560A patent/TW542837B/zh not_active IP Right Cessation
- 1998-07-27 MY MYPI98003421A patent/MY118796A/en unknown
- 1998-07-28 CO CO98042905A patent/CO4970780A1/es unknown
- 1998-07-29 AR ARP980103719A patent/AR015927A1/es active IP Right Grant
- 1998-07-29 EG EG88998A patent/EG24041A/xx active
- 1998-07-30 PE PE1998000682A patent/PE111099A1/es not_active Application Discontinuation
2000
- 2000-01-26 NO NO20000394A patent/NO315118B1/no not_active IP Right Cessation
- 2000-01-27 BG BG104112A patent/BG64448B1/bg unknown
- 2000-01-28 US US09/496,019 patent/US6407108B1/en not_active Expired - Fee Related
2002
- 2002-01-08 US US10/038,777 patent/US20020183326A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO315118B1 (no)	2003-07-14
KR20010022353A (ko)	2001-03-15
CZ290208B6 (cs)	2002-06-12
BR9810829B1 (pt)	2009-08-11
CO4970780A1 (es)	2000-11-07
JP4320118B2 (ja)	2009-08-26
EE04313B1 (et)	2004-06-15
EP1001955B1 (en)	2001-10-17
WO1999006404A1 (en)	1999-02-11
EP1001955A1 (en)	2000-05-24
UA60339C2 (uk)	2003-10-15
AR015927A1 (es)	2001-05-30
NO20000394D0 (no)	2000-01-26
CN1266434A (zh)	2000-09-13
ES2137113B1 (es)	2000-09-16
ZA986248B (en)	1999-02-05
CN1135231C (zh)	2004-01-21
ES2162466T3 (es)	2001-12-16
PE111099A1 (es)	1999-11-18
US20020183326A1 (en)	2002-12-05
BR9810829A (pt)	2000-07-25
CZ2000333A3 (cs)	2000-05-17
ES2137113A1 (es)	1999-12-01
RU2202552C2 (ru)	2003-04-20
ID24506A (id)	2000-07-20
TR200000243T2 (tr)	2000-07-21
PT1001955E (pt)	2002-02-28
DE69802100D1 (de)	2001-11-22
PL191031B1 (pl)	2006-03-31
NZ502356A (en)	2001-03-30
HUP0004708A2 (hu)	2001-07-30
BG64448B1 (en)	2005-02-28
BG104112A (en)	2001-01-31
IL134081A0 (en)	2001-04-30
SK284046B6 (sk)	2004-08-03
EG24041A (en)	2008-04-03
DE69802100T2 (de)	2002-03-14
JP2001512121A (ja)	2001-08-21
DK1001955T3 (da)	2001-11-19
TW542837B (en)	2003-07-21
CA2298935A1 (en)	1999-02-11
MY118796A (en)	2005-01-31
NO20000394L (no)	2000-03-27
US6407108B1 (en)	2002-06-18
HUP0004708A3 (en)	2002-11-28
PL338214A1 (en)	2000-10-09
HK1024914A1 (en)	2000-10-27
AU8861298A (en)	1999-02-22
IL134081A (en)	2004-02-08
ATE207069T1 (de)	2001-11-15
SI1001955T1 (en)	2002-02-28
AU737709B2 (en)	2001-08-30
SK862000A3 (en)	2000-07-11

Publication	Publication Date	Title
EE200000052A (et)	2000-10-16	1,2,4-triasolo[4,3-b]pürido[3,2-d]püridasiini derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon ning nende kasutamine
HUP0202494A2 (en)	2002-10-28	Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105081A3 (en)	2004-11-29	Triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0100202A3 (en)	2001-10-29	Novel triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0000720A3 (en)	2001-01-29	Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use
HUP0001805A3 (en)	2002-09-30	6-benzyl-1,5-dihydro-pyrazolo[3,4-d]-pyrimidin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0004333A3 (en)	2001-11-28	Novel triazolo [4,5-d] pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing thereof
HUP0003826A3 (en)	2001-11-28	Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof
HUP9801602A3 (en)	1999-01-28	Imidazo[1,2-a]pyridine derivatives, process for their production, pharmaceutical compositions and use thereof
HUP0001507A3 (en)	2002-01-28	Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0200450A3 (en)	2004-04-28	Cephen derivatives containing an imidazo[4,5-b]pyridiniummethyl moiety, process for their preparation and pharmaceutical compositions of the same
HUP0002104A3 (en)	2002-03-28	Pyrazolo[3,4-d]pyrimidinedione derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0200207A3 (en)	2004-07-28	Substituted 2-aryl-3-(hetroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compositions and methods for their preparation
HUP0002839A3 (en)	2001-04-28	Pyrrolo[3,4-d]pyrimidinone derivatives, their use, pharmaceutical compositions containing them, process for their preparation
HUP0001922A3 (en)	2001-02-28	Pyrazolo[4,3-c]-pyridine derivatives, pharmaceutical compositions thereof against insulin resistance, intermediates and process for their preparation
EE9900155A (et)	1999-12-15	1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
PL307328A1 (en)	1995-08-21	Novel derivatives of imidazo [1,2-a] pyridine and method of obtaining them as well as pharmaceutical preparation and method of preparing same
IL128142A0 (en)	1999-11-30	3-Substituted pyrido [4',3':4,5] thieno [2,3-d] pyrimidine derivatives their preparation and their use
HUP0105054A3 (en)	2002-12-28	Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0105132A3 (en)	2002-12-28	Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions
HUP0202624A3 (en)	2004-11-29	Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP9901038A3 (en)	2000-04-28	Pyrido[2,3-b]pyrazine derivatives, pharmaceutical compositions containing these compounds, process for the preparation and use of the ingredients and compositions
HUP0003394A3 (en)	2003-04-28	Pyrido[2,3-b][1,5]benzodiazepine derivatives, their use, process for their preparation and pharmaceutical compositions containing them
HU0003979D0 (en)	2000-12-28	Process for the preparation of 3-pyridylsulphonil-pyrazolo[4,3-d] pyrimidin-7-one derivatives and intermediates thereof
HUP0002736A3 (en)	2001-04-28	3-substituted pyrido [3',4':4,5]thieno[2,3-d]pyrimidine derivatives, and their use for the preparation of pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2011-04-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20100713